PLAY PODCASTS
Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis

Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis

Neurology Minute · Anna Rehbein

October 3, 20232m 27s

Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

Dr. Rae Bacharach discusses the paper, "Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis".

Show references: https://jamanetwork.com/journals/jamaneurology/article-abstract/2806000